Non-Invasive Prenatal Testing (NIPT)

Original price was: ₹18,000.00.Current price is: ₹12,000.00.

What is NIPT Test?
MedGenome Claria NIPT is a simple, safe, and non invasive prenatal screening test that provides assurance to expectant parents with accurate genetic information about their baby. Claria NIPT Test uses advanced bioinformatics technology to evaluate fetal DNA (of placental origin) in maternal blood to identify genetic variations leading to disorders.
What are the conditions that Claria NIPT, NIPT Twins, and Claria NIPT Advanced can detect?
Claria NIPT can detect common Aneuploidies and Sex Chromosome Abnormalities.

Claria NIPT
Trisomy 21 (Down Syndrome)
Trisomy 18 (Edwards’ Syndrome)
Trisomy 13 (Patau syndrome)
Turner Syndrome (Monosomy X/XO)
Klinefelter Syndrome (XXY)
Triple X (XXX)
Jacob’s Syndrome (XYY)
Claria NIPT Advanced
Rare Autosomal Aneuploidies (RAA) include trisomies in chromosomes other than 21, 18 and 13 and monosomies in all 22 chromosomes.
Claria NIPT Advanced screens for RAAs in addition to Trisomy 13, 18, 21 and sex chromosomes.
NIPT Twins
Trisomy 21
Trisomy 18
Trisomy 13

+919092026085
Categories: ,

Description

Method: DNA Sequencing
Comment: Samples received on holidays will be reported in next schedule / next working day.
Price: 12000.00
Report: Sample Mon / Wed / Fri by 9 am; Report 6 Working days
Usage: This is a non-invasive assay used for the detection of Fetal trisomies like Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18) and Patau’s syndrome (Trisomy 13) using Maternal peripheral blood. The specificity of the test is >99% with a false positive rate of <0.05%.
Doctor Specialty: Gynecologist
Disease: Prenatal Diagnosis
Components: *Trisomy detection for 13, 18 & 21 Chromosomes
Courier Charges: 0.00
Home Collection: Not Available
Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Test is valid between 10-24 weeks of gestation. Duly filled Form G AND MBFD/NIPT consent form (Form 21) is mandatory. Samples shall be accepted only from registered genetics clinics under PCPNDT Act.

What is NIPT Test?
MedGenome Claria NIPT is a simple, safe, and non invasive prenatal screening test that provides assurance to expectant parents with accurate genetic information about their baby. Claria NIPT Test uses advanced bioinformatics technology to evaluate fetal DNA (of placental origin) in maternal blood to identify genetic variations leading to disorders.
What are the conditions that Claria NIPT, NIPT Twins, and Claria NIPT Advanced can detect?
Claria NIPT can detect common Aneuploidies and Sex Chromosome Abnormalities.

Claria NIPT
Trisomy 21 (Down Syndrome)
Trisomy 18 (Edwards’ Syndrome)
Trisomy 13 (Patau syndrome)
Turner Syndrome (Monosomy X/XO)
Klinefelter Syndrome (XXY)
Triple X (XXX)
Jacob’s Syndrome (XYY)
Claria NIPT Advanced
Rare Autosomal Aneuploidies (RAA) include trisomies in chromosomes other than 21, 18 and 13 and monosomies in all 22 chromosomes.
Claria NIPT Advanced screens for RAAs in addition to Trisomy 13, 18, 21 and sex chromosomes.
NIPT Twins
Trisomy 21
Trisomy 18
Trisomy 13